0001209191-18-059875.txt : 20181126 0001209191-18-059875.hdr.sgml : 20181126 20181126092935 ACCESSION NUMBER: 0001209191-18-059875 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20181123 FILED AS OF DATE: 20181126 DATE AS OF CHANGE: 20181126 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: CAUWENBERGH GEERT CENTRAL INDEX KEY: 0001285648 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36304 FILM NUMBER: 181200065 MAIL ADDRESS: STREET 1: 1 STULTS DRIVE CITY: PLAINSBORO STATE: NJ ZIP: 08536 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Phio Pharmaceuticals Corp. CENTRAL INDEX KEY: 0001533040 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 257 SIMARANO DRIVE STREET 2: SUITE 101 CITY: MARLBOROUGH STATE: MA ZIP: 01752 BUSINESS PHONE: (508) 767-3861 MAIL ADDRESS: STREET 1: 257 SIMARANO DRIVE STREET 2: SUITE 101 CITY: MARLBOROUGH STATE: MA ZIP: 01752 FORMER COMPANY: FORMER CONFORMED NAME: RXi Pharmaceuticals Corp DATE OF NAME CHANGE: 20111019 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2018-11-23 0 0001533040 Phio Pharmaceuticals Corp. PHIO 0001285648 CAUWENBERGH GEERT C/O PHIO PHARMACEUTICALS CORP. 257 SIMARANO DRIVE, SUITE 101 MARLBOROUGH MA 01752 1 1 0 0 Chief Executive Officer Common stock, $0.0001 par value 2018-11-23 4 A 0 25941 0.3121 A 189233 D Common stock, $0.0001 par value 450 I By spouse As reported on a Current Report on Form 8-K filed on September 4, 2018, the reporting person has elected to receive a portion of his compensation in stock in lieu of cash. Accordingly, on November 23, 2018, the reporting person received a total of 25,941 shares of common stock from the Company in lieu of $8,096.16 of cash compensation, which includes base salary, that was payable on such date. Caitlin Kontulis, attorney-in-fact 2018-11-26